Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

FLT3L Release by Natural Killer Cells Enhances Response to Radioimmunotherapy in Preclinical Models of HNSCC
Thomas E. Bickett, Michael W. Knitz, Laurel B. Darragh, et al.
Clinical Cancer Research (2021) Vol. 27, Iss. 22, pp. 6235-6249
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Natural killer cell-related prognosis signature characterizes immune landscape and predicts prognosis of HNSCC
Hao Chi, Xixi Xie, Yingjie Yan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 100
Radiation-induced tumor immune microenvironments and potential targets for combination therapy
Siyu Guo, Yihan Yao, Yang Tang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 71
Targeting oral tumor microenvironment for effective therapy
Hendrik Setia Budi, Bagher Farhood
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 26
Innate Immune Cells in Tumour Microenvironment: A New Frontier in Cancer Immunotherapy
Changhui Li, Xinyu Yu, Xinyan Han, et al.
iScience (2024) Vol. 27, Iss. 9, pp. 110750-110750
Open Access | Times Cited: 9
Antigen cross-presentation by dendritic cells: A critical axis in cancer immunotherapy
Christine Moussion, Lélia Delamarre
Seminars in Immunology (2023) Vol. 71, pp. 101848-101848
Closed Access | Times Cited: 17
When DNA damage responses meet tumor immunity: From mechanism to therapeutic opportunity
Dong Pan, Qi Wang, AiHua Shen, et al.
International Journal of Cancer (2024) Vol. 155, Iss. 3, pp. 384-399
Closed Access | Times Cited: 8
Natural killer cell-related prognostic risk model predicts prognosis and treatment outcomes in triple-negative breast cancer
Zundong Liu, Mingji Ding, Pengjun Qiu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 14
The mouse oral carcinoma (MOC) model: A 10-year retrospective on model development and head and neck cancer investigations
Michihisa Kono, Shin Saito, Ann Marie Egloff, et al.
Oral Oncology (2022) Vol. 132, pp. 106012-106012
Open Access | Times Cited: 21
Selective targeting of IL2Rβγ combined with radiotherapy triggers CD8- and NK-mediated immunity, abrogating metastasis in HNSCC
Jacob Gadwa, Maria Amann, Thomas E. Bickett, et al.
Cell Reports Medicine (2023) Vol. 4, Iss. 8, pp. 101150-101150
Open Access | Times Cited: 13
High FLT3 expression increases immune‐cell infiltration in the tumor microenvironment and correlates with prolonged disease‐free survival in patients with non‐small cell lung cancer
Łukasz Kuncman, Magdalena Orzechowska, Tomasz Milecki, et al.
Molecular Oncology (2024) Vol. 18, Iss. 5, pp. 1316-1326
Open Access | Times Cited: 4
Prospective and genetic analyses implicate lower immunosurveillance in the aetiology of prostate cancer
Karl Smith-Byrne, Mahboubeh Parsaeian, Wing Ching Chan, et al.
Research Square (Research Square) (2025)
Closed Access
Engineered Oncolytic Virus OH2-FLT3L Enhances Antitumor Immunity via Dendritic Cell Activation
Duo Wan, Qi Zhang, Zhenrong Yang, et al.
Deleted Journal (2025) Vol. 33, Iss. 2, pp. 200975-200975
Open Access
Altered extracellular matrix correlates with an immunosuppressive tumor microenvironment and disease progression in younger adults with oral cavity squamous cell carcinoma
Leonard E. Estephan, Kumar Gaurav, Matthew Stewart, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Combining radiotherapy and NK cell-based therapies: The time has come
Jérémy Baude, Emeric Limagne, Riad Ladjohounlou, et al.
International review of cell and molecular biology (2023), pp. 31-60
Closed Access | Times Cited: 8
IL7 in combination with radiotherapy stimulates a memory T-cell response to improve outcomes in HNSCC models
Justin Yu, Jacob Gadwa, Richard B. Ross, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 5
Open Access | Times Cited: 2
Combined flow cytometry natural killer immunophenotyping and KIR/HLA-C genotyping reveal remarkable differences in acute myeloid leukemia patients, but suggest an overall impairment of the natural killer response
Vlad Andrei Cianga, Cristina Rusu, Mariana Pavel, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 4
An investigator-initiated clinical study in patients with refractory or recurrent solid tumors: ‘R-ISV-FOLactis’ trial
Juanjuan Dai, Junmeng Zhu, Lijing Zhu, et al.
Future Oncology (2024) Vol. 20, Iss. 20, pp. 1393-1400
Closed Access | Times Cited: 1
Manipulating the EphB4-ephrinB2 axis to reduce metastasis in HNSCC
Khalid N.M. Abdelazeem, Diemmy Nguyen, Sophia Corbo, et al.
Oncogene (2024)
Open Access | Times Cited: 1
BCG immunotherapy promotes tumor-derived T-cell activation through the FLT3/FLT3LG pathway in bladder cancer
Wei Zhang, Lu Yu, Zhiguang Chang, et al.
Journal of Cancer (2023) Vol. 15, Iss. 3, pp. 623-631
Open Access | Times Cited: 3
Dichotomous effects of cellular expression of STAT3 on tumor growth of HNSCC
Thomas E. Bickett, Michael W. Knitz, Miles Piper, et al.
Molecular Therapy (2021) Vol. 30, Iss. 3, pp. 1149-1162
Open Access | Times Cited: 6
A comprehensive prognostic score for head and neck squamous cancer driver genes and phenotype traits
Wen Zeng, Fangfang Xie, Yiyun Pan, et al.
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Role of Flt3l and Rps15 in ketamine anesthesia
Lin Zhang, Lingyan Xu
Medicine (2024) Vol. 103, Iss. 9, pp. e37123-e37123
Open Access
Manipulating the EphB4-ephrinB2 axis to reduce metastasis in HSNCC
Khalid N.M. Abdelazeem, Diemmy Nguyen, Sophia Corbo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Natural killer cell-associated prognosis model characterizes immune landscape and treatment efficacy of diffuse large B cell lymphoma
Wei Xiao, Kuai Yu, Xuefei Deng, et al.
Cytokine (2024) Vol. 182, pp. 156726-156726
Closed Access
The pro-tumoral and anti-tumoral roles of EphA4 on T regulatory cells and tumor associated macrophages during HNSCC tumor progression
Sophia Corbo, Diemmy Nguyen, Shilpa Bhatia, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Page 1 - Next Page

Scroll to top